Dmitry Balyasny’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Dmitry Balyasny's BIIB Position: Q3 2026 in Review
Dmitry Balyasny increased its Biogen (BIIB) stake by 63% in Q3 2026, buying an estimated $35.2M and bringing the position to 431,125 shares worth $97.4M. The position accounts for 0.11% of the portfolio, ranked #183.
Dmitry Balyasny first reported a position in BIIB in Q4 2014 and has held it in 44 quarters since. The position peaked at $174M in Q4 2017. 1,058 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Dmitry Balyasny held 431,125 shares of Biogen worth $97.4M as of Q3 2026.
- Dmitry Balyasny bought 166,035 Biogen shares in Q3 2026, an estimated $35.2M.
- Biogen made up 0.11% of Dmitry Balyasny's portfolio in Q3 2026, its #183 holding.
- Dmitry Balyasny first reported a position in Biogen in Q4 2014 and has held it in 44 quarters since.
- Dmitry Balyasny's Biogen position peaked at $174M in Q4 2017.
- 1,058 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.